ALA-induced PpIX Fluorescence During Brain Tumor Resection
Quantification of ALA-induced PpIX Fluorescence During Brain Tumor Resection
Sponsor: David W. Roberts
This PHASE1 trial investigates Brain Tumors and is currently ongoing. David W. Roberts leads this study, which shows 14 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting PHASE1
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Jun 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
▶ Show 9 earlier versions
-
Jun 2022 — Jun 2023 [monthly]
Active Not Recruiting PHASE1
-
Jun 2021 — Jun 2022 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE1
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
May 2019 — May 2020 [monthly]
Recruiting PHASE1
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE1
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Apr 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- David W. Roberts
- National Institute of Neurological Disorders and Stroke (NINDS)
For direct contact, visit the study record on ClinicalTrials.gov .